Picture of ME Therapeutics Holdings logo

METX ME Therapeutics Holdings Balance Sheet

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for ME Therapeutics Holdings, fiscal year end - August 31st, CAD millions except per share, conversion factor applied.

2020
August 31st
2021
August 31st
2022
August 31st
2023
August 31st
Period Length:
Source:PROSPECTUSPROSPECTUSPROSPECTUSARS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinal
Cash
Cash and Short Term Investments0.050.0730.0770.647
Net Total Receivables0.020.0020.0230.007
Prepaid Expenses
Total Current Assets0.070.0750.1020.672
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0000
Net Intangible Assets
Total Assets0.070.0750.1020.672
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities0.0060.0330.1740.148
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities0.0460.0930.2340.148
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity0.024-0.018-0.1310.523
Total Liabilities & Shareholders' Equity0.070.0750.1020.672
Total Common Shares Outstanding